ArticleJournal of clinical medicine2024

Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.

Luisa Bertin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.